HYBRID EVENT | BHRT Workshop Series
Course Description
BHRT Part I is a workshop involving an in-depth scientific literature review of HRT fundamentals, case presentations, and case management, an approach designed to help physicians successfully and knowledgeably treat their patients, whether younger or older, male or female, premenopausal, postmenopausal, or andropausal.
After an in-depth literature review of the importance of optimizing hormones for men and women, guidelines for diagnosing, prescribing, monitoring, and adjusting dosages based on both patient symptomatology and lab tests when applicable are delineated. Some of the hormones discussed and their associated benefits include the following:
- Testosterone for men and women
- Estradiol
- Progesterone
- Thyroid
- Melatonin
- DHEA
- Pregnenolone
BHRT Part I is designed to provide the nuts and bolts of hormone replacement therapy. In addition to learning the fundamentals of BHRT, you’ll learn about troubleshooting HRT challenges through literature presentations, case studies, and open discussions.
Once you complete Part I: Discover the Power of BHRT, we encourage you to start seeing patients and recommend for those patients that would benefit. We cover each hormone in detail that includes research, protocols, monitoring, adjusting and case studies. We also provide online Hormone Summary Recommendations and access to the online Forum for case questions as you get started.
- Cross state licensure for the following scenarios:
- Patient who originate in person but are traveling
- Patients who originate in person but then move to another state
- Patient who originate out-of-state
- Patient who travels to initiate care in the state the prescriber is in and then return to their state
- Impacted by writing script or diagnosing and treating versus providing consultive/educational communications
- Medical malpractice coverage for patients whose stated residence is outside the state of healthcare professionals’ office/practice/insurance
- Electronic communication consent/risk mitigation for virtual patients (out of state).
- CURES Act compliance
- Does the provider need to have a license and DEA in the state the prescription is written or the state the patient lives in
- Can controlled substances i.e. testosterone be prescribed via telehealth
- NEW YORK: testosterone is C2 i.e. no telehealth in New York?
- CALIFORNIA: whether publication of medical educational information that is non-allopathic (outside of scientific community consensus) triggers exposure with laws intended to regulate medical information dissemination that allegedly poses public health risks
- NON-SUBSCRIPTION PRACTICES: Are virtual consults for cash medicare/Medicaid compliant or not and why? Are there business and compliance reasons to focus more on subscription pricing?
- Update on pending telehealth legislation
Registration
